Novavax posts quarterly profit on COVID vaccine sales https://ift.tt/ogfqjIO

The company's shares were up nearly 11 per cent at $8.32. The cash-strapped company also entered a stock deal with SK Bioscience worth about $85 million for part payment of a settlement amount owed to the South Korean company for manufacturing Novavax's COVID-19 vaccines.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/Sea7MRb